Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Roche Holding AG

Market Cap 26TCr 33TCr 28TCr 25TCr 46TCr 30,66800Cr 46TCr 3,10900Cr 1,20800Cr 15,11300Cr 1,22100Cr 1,19500Cr 52,38300Cr P/E 2026 *
17.5x
P/E 2027 * 16.3x
Enterprise Value 27TCr 34TCr 29TCr 26TCr 48TCr 31,89200Cr 48TCr 3,23400Cr 1,25600Cr 15,71700Cr 1,27000Cr 1,24300Cr 54,47400Cr EV / Sales 2026 *
4.34x
EV / Sales 2027 * 4.08x
Free-Float
88.78%
Yield 2026 *
3.05%
Yield 2027 * 3.13%
1 day-2.24%
Current month+0.48%
6 months+1.40%
Current year-1.29%
Current year 311.6
Extreme 311.6
377
1 year 221.3
Extreme 221.3
377
3 years 212.3
Extreme 212.3
377
5 years 212.3
Extreme 212.3
404.1
10 years 202.23
Extreme 202.231
404.1
Manager TitleAgeSince
Chief Executive Officer 51 15/03/2023
Director of Finance/CFO 59 06/06/2011
Chief Operating Officer - 01/10/2025
Director TitleAgeSince
Director/Board Member 68 01/01/1996
Chairman 59 15/03/2023
Director/Board Member 73 03/03/2015
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 33TCr
-1.03%-5.46%+39.81%+142.84% 99TCr
-2.04%-3.87%+52.00%+39.59% 56TCr
-1.98%-3.67%+16.73%+57.11% 39TCr
-2.36%-3.12%+24.71%+12.95% 28TCr
-2.45%-2.88%+24.29%+29.93% 28TCr
-1.91%-0.87%-41.95%-48.26% 20TCr
-0.18%-5.25%+15.83%+46.76% 18TCr
-1.49%-2.18%+14.00%+58.44% 16TCr
-2.45%-3.57%+5.67%-35.85% 15TCr
Average -1.87%+0.30%+16.79%+33.72% 35.44TCr
Weighted average by Cap. -1.74%-0.70%+27.20%+63.09%

Financials

2026 *2027 *
Net sales 6.26TCr 7.79TCr 6.79TCr 5.88TCr 11TCr 7,34000Cr 11TCr 74TCr 29TCr 3,61700Cr 29TCr 29TCr 12,53800Cr 6.51TCr 8.1TCr 7.06TCr 6.12TCr 11TCr 7,63400Cr 12TCr 77TCr 30TCr 3,76200Cr 30TCr 30TCr 13,03900Cr
Net income 1.52TCr 1.9TCr 1.65TCr 1.43TCr 2.68TCr 1,78600Cr 2.7TCr 18TCr 7.03TCr 88TCr 7.12TCr 6.96TCr 3,05200Cr 1.62TCr 2.02TCr 1.76TCr 1.53TCr 2.86TCr 1,90600Cr 2.88TCr 19TCr 7.51TCr 94TCr 7.59TCr 7.43TCr 3,25600Cr
Net Debt 1.04TCr 1.3TCr 1.13TCr 981.37Cr 1.84TCr 1,22400Cr 1.85TCr 12TCr 4.82TCr 60TCr 4.88TCr 4.77TCr 2,09100Cr 375.62Cr 467.66Cr 407.47Cr 353.31Cr 660.98Cr 44TCr 665.62Cr 4.47TCr 1.74TCr 22TCr 1.76TCr 1.72TCr 75TCr
Logo Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Employees
1,03,249
Date Price Change Volume
18/26/18 323.90 CHF 0.00% 1,48,409
17/26/17 323.90 CHF 0.00% 2,89,037
16/26/16 323.90 CHF 0.00% 1,84,548
15/26/15 323.90 CHF 0.00% 2,36,877
12/26/12 323.90 CHF 0.00% 1,94,314
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
327.80CHF
Average target price
358.83CHF
Spread / Average Target
+9.47%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!